Clinical Trials in Detroit

Showing 11981-12000 of 16,931 trials

Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer

NCT02257619

The primary objectives of this study is to evaluate the safety and tolerability of itacitinib in combination with docetaxel and to select doses for further evaluation (Part 1, safety run-in portion).

NSCLC (Non-small Cell Lung Carcinoma)

Incyte Corporation9 participantsStarted Sep 2014

Hot Springs, Arizona, United States • Los Angeles, California, United States • Washington D.C., District of Columbia, United States +13 more locations

COMPLETEDPhase 313 miles

Lesinurad and Febuxostat Combination Extension Study in Gout

NCT01808144

This study will assess the serum uric acid lowering effects and safety of lesinurad in combination with febuxostat over a long-term timeframe.

Gout

Ardea Biosciences, Inc.196 participantsStarted Mar 2013

Birmingham, Alabama, United States • Tempe, Arizona, United States • Glendale, California, United States +69 more locations

Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer

Lesinurad and Febuxostat Combination Extension Study in Gout

Find Trials by Condition in Detroit

A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD

Effectiveness of Aurix Therapy in Pressure Ulcers

Asthma Exacerbation Study

Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 Weeks

Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients

Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer

Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma

Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

Lenalidomide and Idelalisib in Treating Patients With Recurrent Follicular Lymphoma

The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD

Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)

A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease

Health-Related Quality of Life in Gay Men With Localized Prostate Cancer

A Randomized, Multi-center, Open-label, Paired Controlled, Crossover In Vivo Study

Safety and Tolerability Study of an Edible Colon Preparation

Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

Systems of Support Study for Childhood Depression